Trial · NCT01737697
Adverse events645
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 645
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Atrial fibrilliation | Cardiac disorders | Acute Phase: Placebo TID | 0 | 158 | |
| other | Atrial fibrilliation | Cardiac disorders | Acute Phase: Sodium Zirconium Cyclosilicate (ZS) 1.25 g TID | 0 | 154 | |
| other | Atrial fibrilliation | Cardiac disorders | Acute Phase: ZS 2.5 g TID | 0 | 141 | |
| other | Atrial fibrilliation | Cardiac disorders | Acute Phase: ZS 5 g TID | 0 | 157 | |
| other | Atrial fibrilliation | Cardiac disorders | Acute Phase: ZS 10 TID | 0 | 143 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: Placebo Matched to ZS 1.25g QD | 0 | 41 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: ZS 1.25 g QD | 0 | 49 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: Placebo Matched to ZS 2.5 g QD | 0 | 46 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: ZS 2.5 g QD | 0 | 54 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: Placebo Matched to ZS 5 g QD | 1 | 68 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: ZS 5 g QD | 0 | 65 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: Placebo Matched to ZS 10 g QD | 0 | 61 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: ZS 10 g QD | 1 | 63 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: ZS 1.25 g QD (Acute Phase: Placebo) | 0 | 46 | |
| other | Atrial fibrilliation | Cardiac disorders | Subacute Phase: ZS 2.5 g QD (Acute Phase; Placebo) | 0 | 50 | |
| other | Constipation | Gastrointestinal disorders | Acute Phase: Placebo TID | 1 | 158 | |
| other | Constipation | Gastrointestinal disorders | Acute Phase: Sodium Zirconium Cyclosilicate (ZS) 1.25 g TID | 1 | 154 | |
| other | Constipation | Gastrointestinal disorders | Acute Phase: ZS 2.5 g TID | 1 | 141 | |
| other | Constipation | Gastrointestinal disorders | Acute Phase: ZS 5 g TID | 1 | 157 | |
| other | Constipation | Gastrointestinal disorders | Acute Phase: ZS 10 TID | 3 | 143 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01737697/events